SCHEMBL25468601

SCHEMBL25468601

CC(=O)N1CCC2(CC1)CC(CNC(C)C)C2

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 7/20 0.38
CYP3A4 P08684 4/20 0.38
CYP2C9 P11712 4/20 0.38
ALDH1A1 P00352 4/20 0.38
EPHX2 P34913 3/20 0.37
EPHX1 P07099 1/20 0.37
CYP1A2 P05177 3/20 0.37
USP2 O75604 2/20 0.37
PIK3CD O00329 1/20 0.37
CYP2C19 P33261 4/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22856408 0.87 NAMPT (0.36) CYP2D6CYP3A4CYP2C9ALDH1A1CYP1A2
SCHEMBL24764434 0.85 ALDH1A1 (0.41) CYP2D6CYP2C9ALDH1A1EPHX2EPHX1
SCHEMBL23945976 0.84 NAMPT (0.36) CYP2D6CYP3A4CYP2C9ALDH1A1EPHX2
SCHEMBL25728446 0.84 ALDH1A1 (0.31) CYP2D6CYP2C9ALDH1A1CYP1A2
SCHEMBL29325176 0.80 PIK3CD (0.43) CYP2D6CYP3A4CYP2C9ALDH1A1EPHX2
SCHEMBL104209 0.79 EPHX2 (0.48) EPHX2EPHX1PIK3CD
SCHEMBL26246996 0.78 HRH3 (0.32) CYP2D6
SCHEMBL25157343 0.78 EPHX2 (0.43) CYP2D6CYP3A4CYP2C9ALDH1A1EPHX2
SCHEMBL24607223 0.77 CYP2D6 (0.43) CYP2D6CYP3A4CYP2C9ALDH1A1CYP1A2
SCHEMBL23992157 0.75 CHRNB2 (0.39) EPHX2EPHX1CYP1A2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192586-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
WO-2023081759-A1 BIFUNCTIONAL PI3K-ALPHA INHIBITORS AND USES THEREOF RELAY THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed